Company intelligence / Profile preview

Emtherapro

Decatur, Georgia, United States

Ownership: Private
Development stage: Other

Overview

Emtherapro's platform has generated significant clinical and biomarker insights in neurodegenerative disease programs, most notably supporting exploratory Phase 2 trials of CT1812 in Alzheimer's, with biomarker data showing disease modification potential by engaging the sigma-2 receptor and normalizing disease pathways in CSF proteomics; early clinical data indicates improved cognitive function and reduced brain atrophy, though commercial approval is not achieved yet.

Therapeutic areas: Neurology
Modalities: Proteomics platform (for diagnostics and precision medicine)Small moleculeBiomarker diagnostics (Companion diagnostic; see platform)
Industry: Biotech

Partnerships

Partnership and clinical data collaboration with Cognito Therapeutics in Alzheimer’s trials (shared biomarker/diagnostic studies; presentations at CTAD)Collaborating with leading academic and clinical experts, likely including Emory University (via incubator)

Beyond the preview

Go deeper on Emtherapro.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emtherapro.

Explore the full profile